I am not a doctor.

Here are the latest numbers from NCCN directly
https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf
Just some excerpts
* unfavorable intermediate-risk prostate cancer treated with RT, short-term ADT (ST-ADT) (4-6 months) is recommended. Concurrent/ adjuvant ADT is preferred over neoadjuvant ADT in this setting.
* For high-risk and very-high-risk prostate cancer treated with EBRT alone, long-term ADT (LT-ADT) (18-36 months) is recommended.
* For high-risk and very-high-risk prostate cancer treated with combination EBRT + brachytherapy, a shortened duration of ADT (12 months) can be considered.

Intermediate is grade group 2 or 3
High-risk and very-high risk GG 4 or 5 with very-high being a PSA over 40

A lot of the other information I provide is from user groups and webinars I attend.

For at least 3 years I have attended weekly Ancan.org Advanced prostate cancer 2 hour meeting. I hear about a lot of people‘s treatment and how it worked. Other than the new people that come in most every week, other people come in to ask questions about problems they’re having
I also attend biweekly’s CSC 2 hour advanced prostate cancer meetings and monthly UCSF meetings

With all of these, I hear about what’s going on with peoples treatments.

I also attend seminars regularly.